CHART 1-44154
巴西结核病诊断专利分析数据集,包含62项专利的注册信息、申请者类型和诊断技术细节,用于研究诊断创新现状。

基本信息
资源简介
CHART 1
【一句话概览】
本数据集是 figshare 公开的结构化表格数据集,收录 1 个文件、合计 19.35 KB,主题涵盖 Tuberculosis、Mycobacterium tuberculosis、Patent、Diagnosis、Intellectual Property,可用于统计建模、特征工程与队列分析,CC BY 4.0 许可开放获取。
【数据集背景】
源站首次发布:2025-07-03。
【数据内容】
源站原始描述:Setting: Tuberculosis remains a global challenge, requiring diagnostic innovations, especially for tuberculosis infection cases. Objective: This study aimed to analyze patent registers related to tuberculosis diagnosis in a Brazilian database, promoting reflections on knowledge translation into clinical practice. Design: This electronic documentary research was carried out in March 2025 in the National Institute of Industrial Property database. Data were assessed descriptively and analyzed by us…
【数据结构与技术规格】
文件数 1 个,合计 19.35 KB。ARTIGO - PATENTES - IJTLD - CHART1.docx:application/vnd.openxmlformats-officedocument.wordprocessingml.document,19.35 KB。数据集 DOI:10.6084/m9.figshare.29474048.v1。
【主题与分类】
源站学科分类:Health equity、Health promotion。主题标签:Tuberculosis、Mycobacterium tuberculosis、Patent、Diagnosis、Intellectual Property。
【适用方向】
结构化表格数据可直接用于统计建模、特征工程与队列分析。
【获取与许可】
源站页面:https://figshare.com/articles/dataset/CHART_1/29474048
使用许可:CC BY 4.0(https://creativecommons.org/licenses/by/4.0/)。
规范引用:Colichi, Rosana Maria Barreto; Filho, Sebastião Pires Ferreira; ALVES, RENATA; Lima, Silvana Andrea Molina (2025). CHART 1. figshare. Dataset
下载信息
注册下载
需要注册 Kaggle 账号并登录后下载,适合需要跟踪下载记录和使用 API 的用户。
暂未开放公开下载
无需注册即可直接获取公开样本或文档,适合快速预览和评估数据集质量。
免登录有偿下载
公开数据集受托下载与技术交付服务。
提供高速下载与技术交付服务(收技术服务费,非数据销售)
暂未开放当前数据集主要来源为 Kaggle 公开托管,完整影像包建议通过原始链接或 Kaggle API 获取。
使用方式
数据集获取(Figshare)
- 源站标题:CHART 1
- DOI:10.6084/m9.figshare.29474048.v1
- 发布日期:2025-07-03
- 文件数:1 个
- 文件总体积:19.35 KB
- 源站页面:https://figshare.com/articles/dataset/CHART_1/29474048
命令行下载
curl -L -o "ARTIGO - PATENTES - IJTLD - CHART1.docx" "https://ndownloader.figshare.com/files/55974836"
文件清单
ARTIGO - PATENTES - IJTLD - CHART1.docx(19.35 KB)
文件总体积 19.35 KB(源站 API 实测)。
数据加载示例(图像类)
from PIL import Image
import glob, os
files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
+ glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
+ glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)
# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path) # 要求 子目录=类别
目录组织与标注格式以源站说明和下载后实际文件为准。
数据说明
Setting: Tuberculosis remains a global challenge, requiring diagnostic innovations, especially for tuberculosis infection cases. Objective: This study aimed to analyze patent registers related to tuberculosis diagnosis in a Brazilian database, promoting reflections on knowledge translation into clinical practice. Design: This electronic documentary research was carried out in March 2025 in the National Institute of Industrial Property database. Data were assessed descriptively and analyzed by using absolute and relative frequencies. Results: Of the 62 patents found, 71% were published by 2015, with an average time of 1,274 days between filing and publication. Half of filers were companies or large corporations. Most patents refer to pharmaceutical compositions also intended for treatment and vaccines. Only six complete kits aimed at detecting tuberculosis disease and tuberculosis infection, based on adenosine deaminase, sputum culture, MPB64 protein, fusion proteins or synthetic peptide antigen. Some include assays for strains resistant to isoniazid and rifampicin. Conclusion: The scarcity of registered innovative products reveals gaps in the early diagnosis of tuberculosis, especially in tuberculosis infection. Investments in biotechnology and artificial intelligence may represent promising strategies to strengthen the fight against tuberculosis.
许可
CC BY 4.0
引用
学术使用请引用 DOI 10.6084/m9.figshare.29474048.v1(source: https://figshare.com/articles/dataset/CHART_1/29474048)。
数据缺失?
依托陕西、四川两大基地,我们与超过十家三甲医院建立直接合作关系,覆盖合规授权、采集治理、专业标注、数据交付的全流程,为AI医疗团队提供即拿即用的高质量临床数据。
⚡️ 需要数据支持或标注服务?立即联系我们获取专业方案。




